Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
2(20%)
Results Posted
100%(3 trials)
Terminated
2(20%)

Phase Distribution

Ph not_applicable
3
30%
Ph phase_3
3
30%
Ph phase_1
4
40%

Phase Distribution

4

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
4(40.0%)
Phase 3Large-scale testing
3(30.0%)
N/ANon-phased studies
3(30.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

3 of 6 finished

Non-Completion Rate

50.0%

3 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(3)
Terminated(3)
Other(2)

Detailed Status

Completed3
unknown2
Terminated2
Recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
60.0%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (40.0%)
Phase 33 (30.0%)
N/A3 (30.0%)

Trials by Status

unknown220%
withdrawn110%
terminated220%
completed330%
recruiting220%

Recent Activity

2 active trials
Showing 5 of 10
recruitingphase_3

PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia

NCT06033131
recruitingphase_3

MetfOrmin BenefIts Lower Extremities With Intermittent Claudication

NCT05132439
terminatedphase_3

REMAP Trial for Optimizing Surgical Outcomes at UPMC

NCT03861767
unknownnot_applicable

Metformin Treatment in Polycystic Ovary Syndrome (PCOS)

NCT02198417
unknownnot_applicable

Polycystic Ovary Syndrome Genetics and Treatment Response

NCT01389778
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT06033131Phase 3

PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia

Recruiting
NCT05132439Phase 3

MetfOrmin BenefIts Lower Extremities With Intermittent Claudication

Recruiting
NCT03861767Phase 3

REMAP Trial for Optimizing Surgical Outcomes at UPMC

Terminated
NCT02198417Not Applicable

Metformin Treatment in Polycystic Ovary Syndrome (PCOS)

Unknown
NCT01389778Not Applicable

Polycystic Ovary Syndrome Genetics and Treatment Response

Unknown
NCT00941239Phase 1

Tolerability and Pharmacokinetics of Metformin and Metformin Extended Release (ER)

Completed
NCT02121509Phase 1

Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/750mg) Extended Release in Healthy Subjects

Completed
NCT02084082Phase 1

Bioequivalence of a FDC Tablet of Linagliptin/Metformin (5mg/1000mg) Extended Release in Healthy Subjects

Completed
NCT01816659Phase 1

An Open-Labeled Pilot Study of Biomarker Response Following Short-Term Exposure to Metformin

Terminated
NCT01550900Not Applicable

Prospective Trial of Metformin - Chemoprevention Role

Withdrawn

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10